Laurent Pharmaceuticals' Grant

Laurent Pharmaceuticals raised a round of funding on March 14, 2018. Investors include Cystic Fibrosis Foundation.

Laurent Pharmaceuticals is a Canada-based clinical stage company focusing on rare inflammatory diseases. Laurent's lead drug candidate, LAU-7b, is a Phase 2 ready oral drug addressing the compromised …

Articles about Laurent Pharmaceuticals' Grant: